VERA Vera Therapeutics Inc
Company Analysis
Latest News
🟢 VERA is trading 5% up today as investors position ahead of FDA decision on atacicept
VERA is trading 5% up at $42.14 as investors position ahead of a key FDA decision for its IgA nephropathy treatment, atacicept. • The Biologics License...
🟢 VERA is trading 4.8% up today ahead of FDA PDUFA date for atacicept
VERA is trading 4.8% up at $42.04 as traders position ahead of the FDA’s PDUFA action date for its IgA nephropathy drug, atacicept. - The Biologics License...
🟢 VERA is trading 5.5% up today ahead of pivotal FDA action date for atacicept
VERA is trading 5.5% up today at $41.90 in pre-market action as traders position ahead of a pivotal FDA action date for its lead IgA nephropathy drug,...
🔴 VERA makes sharp 12.1% drop
VERA is trading at $37.51, down 12.1% versus the comparison close of $42.66 during regular trading. This is a price-movement alert; no separate...
🔴 VERA is trading 5.7% down today after no clear company-specific catalyst
VERA is trading at 5.7% down now at $40.22 after no clear company-specific catalyst surfaced in the available news flow. The stock’s move appears consistent...
🟢 VERA is trading 5.7% up today, extending a multi-day rally on atacicept optimism
VERA is trading 5.7% up at $44.88 in pre-market, extending a strong multi-day rally fueled by ongoing positive sentiment around its lead drug, atacicept. •...
🟢 VERA extends move to 5.3% up
VERA is trading at $42.65, up 5.3% versus the comparison close of $40.50 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Vera Therapeutics Inc is trading 4.33% up
VERA is trading at $42.26, up 4.33%.